Cite
HARVARD Citation
Freidlin, B. et al. (2022). A Problematic Biomarker Trial Design. Journal of the National Cancer Institute. pp. 187-190. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Freidlin, B. et al. (2022). A Problematic Biomarker Trial Design. Journal of the National Cancer Institute. pp. 187-190. [Online].